2Prasad S, Waters B, Hill PB, et al. Psychiatric side effect so interferon alpha-2b in patients treated for hepatitis C[J]. Clin Res, 1992,40: 840 - 841.
3Shakil AO, Di Bisceglie AM , Hoofnagle JH. Seizures during alpha interferon therapy [J].J Hepatol, 1996,24: 48.
4Jessner W, Kinaciyan T, Fonnann E, et al. Severe skin reactions during therapy for chronic hepatitis C associated with delayed hypersensitivity to pegylated interferon [ J ]. Hepatology, 2002,36 ( 4 ) : 361.
5Creput C, Auffret N, Samuel D, et al . Cutaneous thrombotic microangiopathy during treatment with alpha-interferon for chronic hepatitis C[J] . J hepatol, 2002,37(6): 872
6Matsuda J, Saitoh N, Gotoh M, et al. High prevalence of antiphospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-2α[J]. Am J Gastroenterol, 1995,90: 1138.
7Kumar KS, Russo MW , Esposito S, et al. Severe pulmonary toxicity of interferon and ribavirin therapy in chronic hepatitis C [J].Am J Gastroenterol,2001,96 ( 1 ) : 127
8Poynard T, Leroy V, Cohard M, et al. Meta-analys is of interferon randomized trials in the treatment of viral hepatitis C B effects of do and duration[J]. Hepatology, 1996,24: 778
9Sevastianos VA, Deutsch M, Dourakis SP, et al. Pegylatied interferon-2b-associated autoimmue thrombocytopenia in a patient with chronic hepatitis C[J].Am J Gastroenterol, 2003,98 (3) : 706
